JPMorgan Chase & Co. Has $993,000 Holdings in Definitive Healthcare Corp. (NASDAQ:DH)

JPMorgan Chase & Co. increased its position in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 431.7% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 222,090 shares of the company’s stock after buying an additional 180,323 shares during the period. JPMorgan Chase & Co. owned 0.19% of Definitive Healthcare worth $993,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. The Manufacturers Life Insurance Company lifted its position in Definitive Healthcare by 17.0% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 22,896 shares of the company’s stock valued at $125,000 after acquiring an additional 3,332 shares in the last quarter. Glenmede Trust Co. NA lifted its holdings in shares of Definitive Healthcare by 41.1% in the third quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company’s stock valued at $82,000 after purchasing an additional 5,362 shares in the last quarter. Point72 DIFC Ltd boosted its position in shares of Definitive Healthcare by 759.9% during the third quarter. Point72 DIFC Ltd now owns 9,296 shares of the company’s stock valued at $42,000 after buying an additional 8,215 shares during the last quarter. Renaissance Technologies LLC grew its holdings in Definitive Healthcare by 50.5% during the second quarter. Renaissance Technologies LLC now owns 28,900 shares of the company’s stock worth $158,000 after buying an additional 9,700 shares in the last quarter. Finally, Intech Investment Management LLC purchased a new stake in Definitive Healthcare in the 3rd quarter valued at $55,000. Institutional investors and hedge funds own 98.67% of the company’s stock.

Insider Buying and Selling at Definitive Healthcare

In related news, insider William Moschella sold 45,000 shares of the stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total value of $211,500.00. Following the transaction, the insider now owns 433,830 shares of the company’s stock, valued at $2,039,001. This represents a 9.40 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 14.84% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on DH shares. Needham & Company LLC reiterated a “hold” rating on shares of Definitive Healthcare in a research note on Thursday, January 16th. Stephens began coverage on shares of Definitive Healthcare in a research report on Friday, December 20th. They issued an “equal weight” rating and a $5.00 price objective for the company. Finally, Barclays reissued an “underweight” rating and set a $4.00 target price on shares of Definitive Healthcare in a research report on Monday, January 13th. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, Definitive Healthcare has a consensus rating of “Hold” and an average target price of $5.72.

Definitive Healthcare Price Performance

NASDAQ DH opened at $4.83 on Friday. The company has a 50-day moving average price of $4.36 and a 200-day moving average price of $4.46. Definitive Healthcare Corp. has a 52 week low of $3.19 and a 52 week high of $10.62. The company has a quick ratio of 2.49, a current ratio of 2.49 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $557.96 million, a P/E ratio of -1.56, a PEG ratio of 3.54 and a beta of 1.41.

Definitive Healthcare (NASDAQ:DH) last announced its quarterly earnings data on Thursday, November 7th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.08 by ($0.03). Definitive Healthcare had a negative net margin of 142.38% and a positive return on equity of 1.76%. The firm had revenue of $62.70 million for the quarter, compared to the consensus estimate of $61.66 million. During the same quarter in the previous year, the business earned $0.01 earnings per share. Equities research analysts anticipate that Definitive Healthcare Corp. will post 0.15 earnings per share for the current year.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.